TW
Todd Watanabe (See Remarks) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $1.5M of ARQT (48,945 sh × $30.36, as filed), executed Nov 24 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.7M
shares × price, as filed
Last traded
Nov 2
Filed Nov 4
Median ADV $51.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $5.7M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
ARQTRecent filings
ARQTSALE
Arcutis Biotherapeutics, Inc.
View filing →
$139K4,377 sh × $31.86
Exec Nov 2
Filed Nov 4 · 6:38 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $114K
4,375 sh × $26.12
Exec Aug 3
Filed Aug 5 · 9:42 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $913K
36,281 sh × $25.16
Exec Mar 2
Filed Mar 3 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $506K
19,833 sh × $25.50
Exec Feb 2
Filed Feb 4 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $1.5M
48,945 sh × $30.36
Exec Nov 24 2025
Filed Nov 24 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $284K
11,478 sh × $24.71
Exec Nov 3 2025
Filed Nov 5 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $1.0M
40,000 sh × $25.03
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET ARQTSALE Arcutis Biotherapeutics, Inc. View filing → $885K
45,000 sh across 3 lots
Exec Oct 1 2025
Filed Oct 3 2025 · 5:30 PM ET More filings →